Overview of Biotech Capital Markets Through Week Ended March 24th, 2023
Let's take a look at some highlights from the Biotech and MedTech/Diagnostics Private and Public Capital Markets and SPAC Activity Through the Week Ended March 24th, 2023.
Biotech: 3 Transactions (2 Follow-Ons and 1 Registered Direct) totaling just over $700 Million
Med Tech: No Current Week Transactions
37 Biotech transaction totaling just over $4.4 Billion v. 2022: 21 Biotech transactions totaling just over $3.2 Billion
6 Med Tech transactions totaling just over $400 Million v. 2022: 3 Med Tech transaction just over $200 Million
Biotech: 53 US Transactions / 19 European Transaction
Med Tech: 34 US Transactions / 13 European Transaction